ZBIO
Zenas BioPharma, Inc.
28.70
+0.12 (+0.42%)
52w low 13.50
44.60 high
48.9% of range
Financial Analysis
| Ratio | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Profitability | |||||
| Operating Margin | -- | -54.3% | -3,277.8% | -2,113.8% | |
| EBITDA Margin | -- | -54.1% | -3,128.4% | -3,704.3% | |
| Net Margin | -- | -74.2% | -3,139.8% | -3,777.4% | |
| FCF Margin | -- | -61.1% | -2,396.1% | -2,073.5% | |
| Returns | |||||
| Return on Equity | 62.0% | 16.4% | -50.2% | -156.0% | |
| Return on Assets | -159.9% | -54.4% | -42.4% | -98.5% | |
| Return on Inv Capital | 39.1% | 13.3% | -50.2% | -153.0% | |
| Liquidity | |||||
| Current Ratio | 2.64x | 2.57x | 6.21x | 5.61x | |
| Quick Ratio | 2.64x | 2.57x | 6.21x | 5.61x | |
| Cash Ratio | 2.59x | 2.44x | 5.58x | 1.77x | |
| Leverage | |||||
| Debt / Equity | -0.01x | -0.09x | 0.00x | 0.01x | |
| Interest Coverage | -- | -- | -- | -50.56x | |
| Equity Multiplier | -0.39x | -0.30x | 1.18x | 1.58x | |
| Efficiency | |||||
| Asset Turnover | 0.00x | 0.73x | 0.01x | 0.03x | |
| Effective Tax Rate | -0.0% | -0.8% | -0.3% | 0.0% | |
| Op CF / Net Income | 0.55x | 0.82x | 0.76x | 0.46x | |
| Investment | |||||
| Capex / Revenue | -- | 0.0% | 2.6% | 350.2% | |
| R&D / Revenue | -- | 120.1% | 2,782.8% | 1,680.6% | |
| SG&A / Revenue | -- | 34.2% | 595.0% | 533.2% | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+100.0%